Aravive (NASDAQ:ARAV) reported quarterly losses of $(0.35) per share. This is a 9.37 percent decrease over losses of $(0.32) per share from the same period last year.
Wells Fargo Maintains Overweight on TransDigm Gr, Lowers Price Target to $620
Wells Fargo analyst Matthew Akers maintains TransDigm Gr (NYSE:TDG) with a Overweight and lowers the price target from $700 to $620.